Corautus Genetics Inc. (Nasdaq: VEGF) - formerly known as GenStar Therapeutics Corporation and Urogen Corp. - is a development stage company dedicated to the development of innovative life sciences products.
Headquartered in San Francisco, California, VIA Pharmaceuticals, Inc. is a drug development company focused on compounds that target inflammation in the blood vessel wall, as an innovative approach to treatment of cardiovascular disease.
These two companies have recently signed a definitive merger agreement.
Under the terms of the Agreement:
The merger will result to a company more focused on therapies against blood vessel wall inflammation.
Find more details from the press release.
Comment Preview